ArticleCancer management and research2020

Clinical Investigation of the Efficacy and Safety of Anlotinib with Immunotherapy in Advanced Non-Small Cell Lung Cancer as Third-Line Therapy: A Retrospective Study.

Shengjie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.